Navigation Links
Prostate Cancer Study: Most Patients Report Satisfaction After Robotic Surgery
Date:12/3/2012

NEW YORK, Dec. 3, 2012 /PRNewswire/ -- The majority of patients undergoing RALP (robot-assisted laparoscopic prostatectomy) surgery for localized prostate cancer do not regret their treatment decision, according to findings published in The Journal of Urology, December 2012, http://www.jurology.com/article/S0022-5347(12)04453-9/abstract. Analysis indicates the primary factors contributing to postoperative quality of life, and therefore satisfaction or dissatisfaction with treatment choice, are pre- and postoperative sexual potency and urinary control.

(Photo: http://photos.prnewswire.com/prnh/20121203/NY22781 )

The study included 953 consecutive prostate cancer treatment patients with RALP performed by Dr. David Samadi, Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at New York's Mount Sinai Medical Center. At a median of 11.1 months after robotic surgery, 74 percent completed questionnaires regarding quality of life and treatment decisional regret. Of these patients, 88 percent reported satisfaction with their decision to have RALP. Dr. Samadi performs custom RALP surgery using the Samadi Modified Assisted Robotic Technique (SMART).

In this study Dr. Samadi and his colleagues sought to define specific factors impacting patient decisional regret following RALP for localized prostate cancer. Their analysis focused on the relationship between independent baseline status and quality of life after surgery, namely patient age and erectile and urinary functions before and after surgery.

"It is encouraging that nearly a year after surgery, the majority of my patients are satisfied with their treatment choice and quality of life," said Dr. Samadi. "I believe these findings highlight the importance of pre-op counseling; working one-on-one with patients and their partners to provide a realistic assessment of before and after functions."

Patient-reported data indicated that those with preexisting erectile dysfunction (ED) have greater difficulty with sexual potency after surgery. In terms of regret, however, men with superior preoperative erectile function were more bothered by postoperative sexual issues that those already experiencing some degree of ED. Additionally, patients with severe baseline lower urinary tract symptoms (LUTS) were more regretful after surgery, despite their preexisting urinary problems.

"What we found," explained Dr. Samadi, "is that patient satisfaction with robotic prostate surgery depends on a range of pre- and postoperative variables. This reinforces the need for patient-specific treatment counseling before surgery and a continuing doctor-patient relationship during post-surgery rehabilitation."

Though not included in this study, ongoing patient data indicates that 96 percent of Dr. Samadi's patients regain urinary continence within two to three months of surgery and sexual potency within 12-24 months. To date, Dr. Samadi has performed more than 4,000 successful SMART prostatectomy surgeries.

Related Links:

The Journal of Urology, December 2012 – Click Here  
http://www.jurology.com/article/S0022-5347(12)04453-9/abstract 
http://www.roboticoncology.com 
http://www.smart-surgery.com


'/>"/>
SOURCE roboticoncology.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/25/2017)... Marietta, GA (PRWEB) , ... April 25, 2017 ... ... implant and instrument solutions, announces the continuation of its strategic partnership with and ... surgeons in developing nations in the safe and effective management of complex spine ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... ... , ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian ... Association’s annual conference, on April 23 in Orlando, FL. , “I am proud that ... of the poor and underserved in other parts of the world,” said Jonathan Linkous, ...
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the ... Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that it ... Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany ...
(Date:4/24/2017)... ... 24, 2017 , ... The bar for just about everything—apparel, eyewear, cars and ... air of pop and film stardom.(1) Not to be left out is that most ... now run the gamut from being encrusted with jewels and precious metals to, at ...
Breaking Medicine News(10 mins):